Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline von Bucci, Marco, Chiotis, Konstantinos, Nordberg, Agneta

Volltext

Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease von Kumar, Amit, Fontana, Igor C., Nordberg, Agneta

Volltext

Tau PET imaging in neurodegenerative tauopathies—still a challenge von Leuzy, Antoine, Chiotis, Konstantinos, Lemoine, Laetitia, Gillberg, Per-Göran, Almkvist, Ove, Rodriguez-Vieitez, Elena, Nordberg, Agneta

Volltext

Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity von Sala, Arianna, Nordberg, Agneta, Rodriguez-Vieitez, Elena

Volltext

Astroglial tracer BU99008 detects multiple binding sites in Alzheimer’s disease brain von Kumar, Amit, Koistinen, Niina A., Malarte, Mona-Lisa, Nennesmo, Inger, Ingelsson, Martin, Ghetti, Bernardino, Lemoine, Laetitia, Nordberg, Agneta

Volltext

Assessing synaptic integrity in Alzheimer’s brain with UCB‐J von Kumar, Amit, Nordberg, Agneta K

Volltext

[18F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer’s disease von Chiotis, Konstantinos, Savitcheva, Irina, Poulakis, Konstantinos, Saint-Aubert, Laure, Wall, Anders, Antoni, Gunnar, Nordberg, Agneta

Volltext

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria von Dubois, Bruno, Prof, Feldman, Howard H, Prof, Jacova, Claudia, PhD, Hampel, Harald, Prof, Molinuevo, José Luis, MD, Blennow, Kaj, MD, DeKosky, Steven T, Prof, Gauthier, Serge, Prof, Selkoe, Dennis, Prof, Bateman, Randall, MD, Cappa, Stefano, MD, Crutch, Sebastian, PhD, Engelborghs, Sebastiaan, MD, Frisoni, Giovanni B, Prof, Fox, Nick C, MD, Galasko, Douglas, Prof, Habert, Marie-Odile, MD, Jicha, Gregory A, MD, Nordberg, Agneta, MD, Pasquier, Florence, Prof, Rabinovici, Gil, MD, Robert, Philippe, Prof, Rowe, Christopher, MD, Salloway, Stephen, Prof, Sarazin, Marie, Prof, Epelbaum, Stéphane, MD, de Souza, Leonardo C, MD, Vellas, Bruno, Prof, Visser, Pieter J, MD, Schneider, Lon, Prof, Stern, Yaakov, Prof, Scheltens, Philip, Prof, Cummings, Jeffrey L, Prof

Volltext

Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases von Malarte, Mona-Lisa, Nordberg, Agneta, Lemoine, Laetitia

Volltext

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease von Rodriguez-Vieitez, Elena, Saint-Aubert, Laure, Carter, Stephen F, Almkvist, Ove, Farid, Karim, Schöll, Michael, Chiotis, Konstantinos, Thordardottir, Steinunn, Graff, Caroline, Wall, Anders, Långström, Bengt, Nordberg, Agneta

Volltext

Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implications von Nordberg, Agneta

Volltext

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG von Carter, Stephen F, Schöll, Michael, Almkvist, Ove, Wall, Anders, Engler, Henry, Långström, Bengt, Nordberg, Agneta

Volltext

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework von Bischof, Gérard N, Dodich, Alessandra, Boccardi, Marina, van Eimeren, Thilo, Festari, Cristina, Barthel, Henryk, Hansson, Oskar, Nordberg, Agneta, Ossenkoppele, Rik, Sabri, Osama, Giovanni, B Frisoni G, Garibotto, Valentina, Drzezga, Alexander

Volltext

SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0 von Minoshima, Satoshi, Drzezga, Alexander E, Barthel, Henryk, Bohnen, Nicolaas, Djekidel, Mehdi, Lewis, David H, Mathis, Chester A, McConathy, Jonathan, Nordberg, Agneta, Sabri, Osama, Seibyl, John P, Stokes, Margaret K, Van Laere, Koen

Volltext

Multi‐tracer comparison in Alzheimer’s disease, Corticobasal Degeneration and Progressive Supranuclear Palsy brains von Malarte, Mona‐Lisa, Kumar, Amit, Nordberg, Agneta K

Volltext

Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease von NORDBERG, Agneta

Volltext

Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework von Garibotto, Valentina, Herholz, Karl, Boccardi, Marina, Picco, Agnese, Varrone, Andrea, Nordberg, Agneta, Nobili, Flavio, Ratib, Osman

Volltext

A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer's disease von Almkvist, Ove, Nordberg, Agneta

Volltext

Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease von Carter, Stephen F., Chiotis, Konstantinos, Nordberg, Agneta, Rodriguez-Vieitez, Elena

Volltext

Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies von Ono, Maiko, Sahara, Naruhiko, Kumata, Katsushi, Ji, Bin, Ni, Ruiqing, Koga, Shunsuke, Dickson, Dennis W, Trojanowski, John Q, Lee, Virginia M-Y, Yoshida, Mari, Hozumi, Isao, Yoshiyama, Yasumasa, van Swieten, John C, Nordberg, Agneta, Suhara, Tetsuya, Zhang, Ming-Rong, Higuchi, Makoto

Volltext